Holocene Advisors, LP Uni Qure N.V. Transaction History

Holocene Advisors, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $11.7 Million - $17.6 Million	688,379 Added 101.14%	1,369,032 $25.7 Million
Q2 2022 Aug 15, 2022	BUY	$13.15 - $20.45 $145,636 - $226,483	11,075 Added 1.65%	680,653 $12.7 Million
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $1.45 Million - $2.13 Million	55,765 Added 9.09%	669,578 $21.4 Million
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $2.97 Million - $3.68 Million	-99,115 Reduced 13.9%	613,813 $18.9 Million
Q1 2021 May 17, 2021	BUY	$29.24 - $42.03 $6.73 Million - $9.68 Million	230,308 Added 47.72%	712,928 $24 Million
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $2.46 Million - $3.53 Million	69,694 Added 16.88%	482,620 $17.4 Million
Q3 2020 Nov 16, 2020	BUY	$35.98 - $47.66 $1.79 Million - $2.37 Million	49,796 Added 13.71%	412,926 $15.2 Million
Q2 2020 Aug 14, 2020	SELL	$45.06 - $67.74 $1.76 Million - $2.65 Million	-39,076 Reduced 9.72%	363,130 $16.4 Million
Q1 2020 May 15, 2020	BUY	$40.01 - $73.97 $2.12 Million - $3.92 Million	53,001 Added 15.18%	402,206 $19.1 Million
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $4.75 Million - $9.54 Million	127,857 Added 57.76%	349,205 $25 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $8.71 Million - $17 Million	221,348 New	221,348 $8.71 Million

153

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $266M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.